Target/Host (Institution) | Ligand | Target/Host Links | Ligand Links | Trg + Lig Links | Ki nM | ΔG° kJ/mole | IC50 nM | Kd nM | EC50/IC50 nM | koff s-1 | kon M-1s-1 | pH | Temp °C |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Genome polyprotein [2420-3010,S282T] (Hepatitis C virus genotype 1b (isolate Con1) (HCV)) | BDBM240845 (US9394331, 140 | US9394331, 52) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 5.67E+4 | n/a | n/a | n/a | n/a | 7.5 | 27 |
Gilead Pharmasset LLC US Patent | Assay Description The HCV NS5B reaction was performed in a 20 μL mixture containing varying concentrations of the test compound, 1 μM of all four natural ribonuc... | US Patent US9394331 (2016) BindingDB Entry DOI: 10.7270/Q2W094TH | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Genome polyprotein [2420-3010,S282T] (Hepatitis C virus genotype 1b (isolate Con1) (HCV)) | BDBM240843 (US9394331, 137 | US9394331, 49) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | >1.00E+5 | n/a | n/a | n/a | n/a | 7.5 | 27 |
Gilead Pharmasset LLC US Patent | Assay Description The HCV NS5B reaction was performed in a 20 μL mixture containing varying concentrations of the test compound, 1 μM of all four natural ribonuc... | US Patent US9394331 (2016) BindingDB Entry DOI: 10.7270/Q2W094TH | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Genome polyprotein [2420-3010,S282T] (Hepatitis C virus genotype 1b (isolate Con1) (HCV)) | BDBM240844 (US9394331, 136 | US9394331, 48) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | >1.00E+5 | n/a | n/a | n/a | n/a | 7.5 | 27 |
Gilead Pharmasset LLC US Patent | Assay Description The HCV NS5B reaction was performed in a 20 μL mixture containing varying concentrations of the test compound, 1 μM of all four natural ribonuc... | US Patent US9394331 (2016) BindingDB Entry DOI: 10.7270/Q2W094TH | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Genome polyprotein [2420-3010] (Hepatitis C virus genotype 1b (isolate Con1) (HCV)) | BDBM240842 (US9394331, 44) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | >1.00E+5 | n/a | n/a | 7.5 | 27 |
Gilead Pharmasset LLC US Patent | Assay Description The HCV NS5B reaction was performed in a 20 μL mixture containing varying concentrations of the test compound, 1 μM of all four natural ribonuc... | US Patent US9394331 (2016) BindingDB Entry DOI: 10.7270/Q2W094TH | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Genome polyprotein [2420-3010] (Hepatitis C virus genotype 1b (isolate Con1) (HCV)) | BDBM240843 (US9394331, 137 | US9394331, 49) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | >1.00E+5 | n/a | n/a | 7.5 | 27 |
Gilead Pharmasset LLC US Patent | Assay Description The HCV NS5B reaction was performed in a 20 μL mixture containing varying concentrations of the test compound, 1 μM of all four natural ribonuc... | US Patent US9394331 (2016) BindingDB Entry DOI: 10.7270/Q2W094TH | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Genome polyprotein [2420-3010] (Hepatitis C virus genotype 1b (isolate Con1) (HCV)) | BDBM240844 (US9394331, 136 | US9394331, 48) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | >1.00E+5 | n/a | n/a | 7.5 | 27 |
Gilead Pharmasset LLC US Patent | Assay Description The HCV NS5B reaction was performed in a 20 μL mixture containing varying concentrations of the test compound, 1 μM of all four natural ribonuc... | US Patent US9394331 (2016) BindingDB Entry DOI: 10.7270/Q2W094TH | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Genome polyprotein [2420-3010] (Hepatitis C virus genotype 1b (isolate Con1) (HCV)) | BDBM240845 (US9394331, 140 | US9394331, 52) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | >5.45E+4 | n/a | n/a | 7.5 | 27 |
Gilead Pharmasset LLC US Patent | Assay Description The HCV NS5B reaction was performed in a 20 μL mixture containing varying concentrations of the test compound, 1 μM of all four natural ribonuc... | US Patent US9394331 (2016) BindingDB Entry DOI: 10.7270/Q2W094TH | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Genome polyprotein [2420-3010] (Hepatitis C virus genotype 1b (isolate Con1) (HCV)) | BDBM240846 (US9394331, 62) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | >2.00E+4 | n/a | n/a | 7.5 | 27 |
Gilead Pharmasset LLC US Patent | Assay Description The HCV NS5B reaction was performed in a 20 μL mixture containing varying concentrations of the test compound, 1 μM of all four natural ribonuc... | US Patent US9394331 (2016) BindingDB Entry DOI: 10.7270/Q2W094TH | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Genome polyprotein [2420-3010] (Hepatitis C virus genotype 1b (isolate Con1) (HCV)) | BDBM240847 (US9394331, 72) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | >2.00E+4 | n/a | n/a | 7.5 | 27 |
Gilead Pharmasset LLC US Patent | Assay Description The HCV NS5B reaction was performed in a 20 μL mixture containing varying concentrations of the test compound, 1 μM of all four natural ribonuc... | US Patent US9394331 (2016) BindingDB Entry DOI: 10.7270/Q2W094TH | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Genome polyprotein [2420-3010] (Hepatitis C virus genotype 1b (isolate Con1) (HCV)) | BDBM240848 (US9394331, 76) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | >1.00E+5 | n/a | n/a | 7.5 | 27 |
Gilead Pharmasset LLC US Patent | Assay Description The HCV NS5B reaction was performed in a 20 μL mixture containing varying concentrations of the test compound, 1 μM of all four natural ribonuc... | US Patent US9394331 (2016) BindingDB Entry DOI: 10.7270/Q2W094TH | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Genome polyprotein [2420-3010] (Hepatitis C virus genotype 1b (isolate Con1) (HCV)) | BDBM240849 (US9394331, 77) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | >2.00E+4 | n/a | n/a | 7.5 | 27 |
Gilead Pharmasset LLC US Patent | Assay Description The HCV NS5B reaction was performed in a 20 μL mixture containing varying concentrations of the test compound, 1 μM of all four natural ribonuc... | US Patent US9394331 (2016) BindingDB Entry DOI: 10.7270/Q2W094TH | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Genome polyprotein [2420-3010] (Hepatitis C virus genotype 1b (isolate Con1) (HCV)) | BDBM240850 (US9394331, 66) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | >2.00E+4 | n/a | n/a | 7.5 | 27 |
Gilead Pharmasset LLC US Patent | Assay Description The HCV NS5B reaction was performed in a 20 μL mixture containing varying concentrations of the test compound, 1 μM of all four natural ribonuc... | US Patent US9394331 (2016) BindingDB Entry DOI: 10.7270/Q2W094TH | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Genome polyprotein [2420-3010] (Hepatitis C virus genotype 1b (isolate Con1) (HCV)) | BDBM240851 (US9394331, 114) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 2.06E+4 | n/a | n/a | 7.5 | 27 |
Gilead Pharmasset LLC US Patent | Assay Description The HCV NS5B reaction was performed in a 20 μL mixture containing varying concentrations of the test compound, 1 μM of all four natural ribonuc... | US Patent US9394331 (2016) BindingDB Entry DOI: 10.7270/Q2W094TH | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Genome polyprotein [2420-3010] (Hepatitis C virus genotype 1b (isolate Con1) (HCV)) | BDBM240852 (US9394331, 115) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 2.85E+4 | n/a | n/a | 7.5 | 27 |
Gilead Pharmasset LLC US Patent | Assay Description The HCV NS5B reaction was performed in a 20 μL mixture containing varying concentrations of the test compound, 1 μM of all four natural ribonuc... | US Patent US9394331 (2016) BindingDB Entry DOI: 10.7270/Q2W094TH | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Genome polyprotein [2420-3010] (Hepatitis C virus genotype 1b (isolate Con1) (HCV)) | BDBM240853 (US9394331, 116) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 2.83E+4 | n/a | n/a | 7.5 | 27 |
Gilead Pharmasset LLC US Patent | Assay Description The HCV NS5B reaction was performed in a 20 μL mixture containing varying concentrations of the test compound, 1 μM of all four natural ribonuc... | US Patent US9394331 (2016) BindingDB Entry DOI: 10.7270/Q2W094TH | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Genome polyprotein [2420-3010] (Hepatitis C virus genotype 1b (isolate Con1) (HCV)) | BDBM240854 (US9394331, 117) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 1.67E+4 | n/a | n/a | 7.5 | 27 |
Gilead Pharmasset LLC US Patent | Assay Description The HCV NS5B reaction was performed in a 20 μL mixture containing varying concentrations of the test compound, 1 μM of all four natural ribonuc... | US Patent US9394331 (2016) BindingDB Entry DOI: 10.7270/Q2W094TH | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Genome polyprotein [2420-3010] (Hepatitis C virus genotype 1b (isolate Con1) (HCV)) | BDBM240855 (US9394331, 113) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 1.55E+3 | n/a | n/a | 7.5 | 27 |
Gilead Pharmasset LLC US Patent | Assay Description The HCV NS5B reaction was performed in a 20 μL mixture containing varying concentrations of the test compound, 1 μM of all four natural ribonuc... | US Patent US9394331 (2016) BindingDB Entry DOI: 10.7270/Q2W094TH | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Genome polyprotein [2420-3010] (Hepatitis C virus genotype 1b (isolate Con1) (HCV)) | BDBM240856 (US9394331, 118 | US9394331, 119) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 1.49E+3 | n/a | n/a | 7.5 | 27 |
Gilead Pharmasset LLC US Patent | Assay Description The HCV NS5B reaction was performed in a 20 μL mixture containing varying concentrations of the test compound, 1 μM of all four natural ribonuc... | US Patent US9394331 (2016) BindingDB Entry DOI: 10.7270/Q2W094TH | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Genome polyprotein [2420-3010] (Hepatitis C virus genotype 1b (isolate Con1) (HCV)) | BDBM240856 (US9394331, 118 | US9394331, 119) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 4.52E+3 | n/a | n/a | 7.5 | 27 |
Gilead Pharmasset LLC US Patent | Assay Description The HCV NS5B reaction was performed in a 20 μL mixture containing varying concentrations of the test compound, 1 μM of all four natural ribonuc... | US Patent US9394331 (2016) BindingDB Entry DOI: 10.7270/Q2W094TH | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Genome polyprotein [2420-3010] (Hepatitis C virus genotype 1b (isolate Con1) (HCV)) | BDBM240858 (US9394331, 120 | US9394331, 121) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 390 | n/a | n/a | 7.5 | 27 |
Gilead Pharmasset LLC US Patent | Assay Description The HCV NS5B reaction was performed in a 20 μL mixture containing varying concentrations of the test compound, 1 μM of all four natural ribonuc... | US Patent US9394331 (2016) BindingDB Entry DOI: 10.7270/Q2W094TH | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Genome polyprotein [2420-3010] (Hepatitis C virus genotype 1b (isolate Con1) (HCV)) | BDBM240858 (US9394331, 120 | US9394331, 121) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 9.31E+3 | n/a | n/a | 7.5 | 27 |
Gilead Pharmasset LLC US Patent | Assay Description The HCV NS5B reaction was performed in a 20 μL mixture containing varying concentrations of the test compound, 1 μM of all four natural ribonuc... | US Patent US9394331 (2016) BindingDB Entry DOI: 10.7270/Q2W094TH | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Genome polyprotein [2420-3010] (Hepatitis C virus genotype 1b (isolate Con1) (HCV)) | BDBM240860 (US9394331, 122) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 857 | n/a | n/a | 7.5 | 27 |
Gilead Pharmasset LLC US Patent | Assay Description The HCV NS5B reaction was performed in a 20 μL mixture containing varying concentrations of the test compound, 1 μM of all four natural ribonuc... | US Patent US9394331 (2016) BindingDB Entry DOI: 10.7270/Q2W094TH | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Genome polyprotein [2420-3010] (Hepatitis C virus genotype 1b (isolate Con1) (HCV)) | BDBM240861 (US9394331, 123) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 310 | n/a | n/a | 7.5 | 27 |
Gilead Pharmasset LLC US Patent | Assay Description The HCV NS5B reaction was performed in a 20 μL mixture containing varying concentrations of the test compound, 1 μM of all four natural ribonuc... | US Patent US9394331 (2016) BindingDB Entry DOI: 10.7270/Q2W094TH | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Genome polyprotein [2420-3010] (Hepatitis C virus genotype 1b (isolate Con1) (HCV)) | BDBM240862 (US9394331, 124) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 566 | n/a | n/a | 7.5 | 27 |
Gilead Pharmasset LLC US Patent | Assay Description The HCV NS5B reaction was performed in a 20 μL mixture containing varying concentrations of the test compound, 1 μM of all four natural ribonuc... | US Patent US9394331 (2016) BindingDB Entry DOI: 10.7270/Q2W094TH | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Genome polyprotein [2420-3010] (Hepatitis C virus genotype 1b (isolate Con1) (HCV)) | BDBM240863 (US9394331, 125) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 4.42E+3 | n/a | n/a | 7.5 | 27 |
Gilead Pharmasset LLC US Patent | Assay Description The HCV NS5B reaction was performed in a 20 μL mixture containing varying concentrations of the test compound, 1 μM of all four natural ribonuc... | US Patent US9394331 (2016) BindingDB Entry DOI: 10.7270/Q2W094TH | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Genome polyprotein [2420-3010] (Hepatitis C virus genotype 1b (isolate Con1) (HCV)) | BDBM240864 (US9394331, 126 | US9394331, 127) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 274 | n/a | n/a | 7.5 | 27 |
Gilead Pharmasset LLC US Patent | Assay Description The HCV NS5B reaction was performed in a 20 μL mixture containing varying concentrations of the test compound, 1 μM of all four natural ribonuc... | US Patent US9394331 (2016) BindingDB Entry DOI: 10.7270/Q2W094TH | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Genome polyprotein [2420-3010] (Hepatitis C virus genotype 1b (isolate Con1) (HCV)) | BDBM240864 (US9394331, 126 | US9394331, 127) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 3.10E+3 | n/a | n/a | 7.5 | 27 |
Gilead Pharmasset LLC US Patent | Assay Description The HCV NS5B reaction was performed in a 20 μL mixture containing varying concentrations of the test compound, 1 μM of all four natural ribonuc... | US Patent US9394331 (2016) BindingDB Entry DOI: 10.7270/Q2W094TH | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Genome polyprotein [2420-3010] (Hepatitis C virus genotype 1b (isolate Con1) (HCV)) | BDBM240866 (US9394331, 128 | US9394331, 129) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 450 | n/a | n/a | 7.5 | 27 |
Gilead Pharmasset LLC US Patent | Assay Description The HCV NS5B reaction was performed in a 20 μL mixture containing varying concentrations of the test compound, 1 μM of all four natural ribonuc... | US Patent US9394331 (2016) BindingDB Entry DOI: 10.7270/Q2W094TH | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Genome polyprotein [2420-3010] (Hepatitis C virus genotype 1b (isolate Con1) (HCV)) | BDBM240866 (US9394331, 128 | US9394331, 129) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 670 | n/a | n/a | 7.5 | 27 |
Gilead Pharmasset LLC US Patent | Assay Description The HCV NS5B reaction was performed in a 20 μL mixture containing varying concentrations of the test compound, 1 μM of all four natural ribonuc... | US Patent US9394331 (2016) BindingDB Entry DOI: 10.7270/Q2W094TH | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Genome polyprotein [2420-3010] (Hepatitis C virus genotype 1b (isolate Con1) (HCV)) | BDBM240868 (US9394331, 130 | US9394331, 131) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 8.65E+3 | n/a | n/a | 7.5 | 27 |
Gilead Pharmasset LLC US Patent | Assay Description The HCV NS5B reaction was performed in a 20 μL mixture containing varying concentrations of the test compound, 1 μM of all four natural ribonuc... | US Patent US9394331 (2016) BindingDB Entry DOI: 10.7270/Q2W094TH | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Genome polyprotein [2420-3010] (Hepatitis C virus genotype 1b (isolate Con1) (HCV)) | BDBM240868 (US9394331, 130 | US9394331, 131) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 1.17E+4 | n/a | n/a | 7.5 | 27 |
Gilead Pharmasset LLC US Patent | Assay Description The HCV NS5B reaction was performed in a 20 μL mixture containing varying concentrations of the test compound, 1 μM of all four natural ribonuc... | US Patent US9394331 (2016) BindingDB Entry DOI: 10.7270/Q2W094TH | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Genome polyprotein [2420-3010] (Hepatitis C virus genotype 1b (isolate Con1) (HCV)) | BDBM240870 (US9394331, 132) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | >2.00E+4 | n/a | n/a | 7.5 | 27 |
Gilead Pharmasset LLC US Patent | Assay Description The HCV NS5B reaction was performed in a 20 μL mixture containing varying concentrations of the test compound, 1 μM of all four natural ribonuc... | US Patent US9394331 (2016) BindingDB Entry DOI: 10.7270/Q2W094TH | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Genome polyprotein [2420-3010] (Hepatitis C virus genotype 1b (isolate Con1) (HCV)) | BDBM240871 (US9394331, 133) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | >2.00E+4 | n/a | n/a | 7.5 | 27 |
Gilead Pharmasset LLC US Patent | Assay Description The HCV NS5B reaction was performed in a 20 μL mixture containing varying concentrations of the test compound, 1 μM of all four natural ribonuc... | US Patent US9394331 (2016) BindingDB Entry DOI: 10.7270/Q2W094TH | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Genome polyprotein [2420-3010] (Hepatitis C virus genotype 1b (isolate Con1) (HCV)) | BDBM240872 (US9394331, 134) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 1.40E+4 | n/a | n/a | 7.5 | 27 |
Gilead Pharmasset LLC US Patent | Assay Description The HCV NS5B reaction was performed in a 20 μL mixture containing varying concentrations of the test compound, 1 μM of all four natural ribonuc... | US Patent US9394331 (2016) BindingDB Entry DOI: 10.7270/Q2W094TH | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Genome polyprotein [2420-3010] (Hepatitis C virus genotype 1b (isolate Con1) (HCV)) | BDBM240838 (US9394331, 135 | US9394331, 32) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | >1.00E+5 | n/a | n/a | 7.5 | 27 |
Gilead Pharmasset LLC US Patent | Assay Description The HCV NS5B reaction was performed in a 20 μL mixture containing varying concentrations of the test compound, 1 μM of all four natural ribonuc... | US Patent US9394331 (2016) BindingDB Entry DOI: 10.7270/Q2W094TH | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Genome polyprotein [2420-3010] (Hepatitis C virus genotype 1b (isolate Con1) (HCV)) | BDBM240844 (US9394331, 136 | US9394331, 48) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 3.94E+4 | n/a | n/a | 7.5 | 27 |
Gilead Pharmasset LLC US Patent | Assay Description The HCV NS5B reaction was performed in a 20 μL mixture containing varying concentrations of the test compound, 1 μM of all four natural ribonuc... | US Patent US9394331 (2016) BindingDB Entry DOI: 10.7270/Q2W094TH | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Genome polyprotein [2420-3010] (Hepatitis C virus genotype 1b (isolate Con1) (HCV)) | BDBM240843 (US9394331, 137 | US9394331, 49) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | >4.53E+4 | n/a | n/a | 7.5 | 27 |
Gilead Pharmasset LLC US Patent | Assay Description The HCV NS5B reaction was performed in a 20 μL mixture containing varying concentrations of the test compound, 1 μM of all four natural ribonuc... | US Patent US9394331 (2016) BindingDB Entry DOI: 10.7270/Q2W094TH | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Genome polyprotein [2420-3010] (Hepatitis C virus genotype 1b (isolate Con1) (HCV)) | BDBM240839 (US9394331, 138 | US9394331, 50) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | >1.00E+5 | n/a | n/a | 7.5 | 27 |
Gilead Pharmasset LLC US Patent | Assay Description The HCV NS5B reaction was performed in a 20 μL mixture containing varying concentrations of the test compound, 1 μM of all four natural ribonuc... | US Patent US9394331 (2016) BindingDB Entry DOI: 10.7270/Q2W094TH | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Genome polyprotein [2420-3010] (Hepatitis C virus genotype 1b (isolate Con1) (HCV)) | BDBM240841 (US9394331, 139 | US9394331, 51) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | >1.00E+5 | n/a | n/a | 7.5 | 27 |
Gilead Pharmasset LLC US Patent | Assay Description The HCV NS5B reaction was performed in a 20 μL mixture containing varying concentrations of the test compound, 1 μM of all four natural ribonuc... | US Patent US9394331 (2016) BindingDB Entry DOI: 10.7270/Q2W094TH | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Genome polyprotein [2420-3010] (Hepatitis C virus genotype 1b (isolate Con1) (HCV)) | BDBM240845 (US9394331, 140 | US9394331, 52) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | >8.48E+3 | n/a | n/a | 7.5 | 27 |
Gilead Pharmasset LLC US Patent | Assay Description The HCV NS5B reaction was performed in a 20 μL mixture containing varying concentrations of the test compound, 1 μM of all four natural ribonuc... | US Patent US9394331 (2016) BindingDB Entry DOI: 10.7270/Q2W094TH | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Genome polyprotein [2420-3010] (Hepatitis C virus genotype 1b (isolate Con1) (HCV)) | BDBM240841 (US9394331, 139 | US9394331, 51) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | >1.00E+5 | n/a | n/a | 7.5 | 27 |
Gilead Pharmasset LLC US Patent | Assay Description The HCV NS5B reaction was performed in a 20 μL mixture containing varying concentrations of the test compound, 1 μM of all four natural ribonuc... | US Patent US9394331 (2016) BindingDB Entry DOI: 10.7270/Q2W094TH | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Genome polyprotein [2420-3010] (Hepatitis C virus genotype 1b (isolate Con1) (HCV)) | BDBM240840 (US9394331, 36) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | >1.00E+5 | n/a | n/a | 7.5 | 27 |
Gilead Pharmasset LLC US Patent | Assay Description The HCV NS5B reaction was performed in a 20 μL mixture containing varying concentrations of the test compound, 1 μM of all four natural ribonuc... | US Patent US9394331 (2016) BindingDB Entry DOI: 10.7270/Q2W094TH | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Genome polyprotein [2420-3010] (Hepatitis C virus genotype 1b (isolate Con1) (HCV)) | BDBM240838 (US9394331, 135 | US9394331, 32) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | >1.00E+5 | n/a | n/a | 7.5 | 27 |
Gilead Pharmasset LLC US Patent | Assay Description The HCV NS5B reaction was performed in a 20 μL mixture containing varying concentrations of the test compound, 1 μM of all four natural ribonuc... | US Patent US9394331 (2016) BindingDB Entry DOI: 10.7270/Q2W094TH | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Genome polyprotein [2420-3010] (Hepatitis C virus genotype 1b (isolate Con1) (HCV)) | BDBM240839 (US9394331, 138 | US9394331, 50) | PDB UniProtKB/SwissProt GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | >1.00E+5 | n/a | n/a | 7.5 | 27 |
Gilead Pharmasset LLC US Patent | Assay Description The HCV NS5B reaction was performed in a 20 μL mixture containing varying concentrations of the test compound, 1 μM of all four natural ribonuc... | US Patent US9394331 (2016) BindingDB Entry DOI: 10.7270/Q2W094TH | |||||||||||
More data for this Ligand-Target Pair |